Abstract
cCD79a and IgH VDJ/DJ rearrangements are considered to be relatively specific for B lymphoid precursors. We looked for both in cCD3+, CD7+, CD19- T-ALLs classified by TCR status into αβ or γδ/immature (IM) lineages, with individualization of HOX11L2+ T-ALLs since they represent an intermediate αβ/γδ category. cCD79a was expressed at low levels in 47% of T-ALL and was most frequent in IMγ T-ALLs. IgH rearrangements were common in γδ/IM (45%) and HOX11L2+ (35%) T-ALLs compared to HOX11L2-negative cases (3%; P<0.001). CD127 (IL7Rα) expression was also more common in the γδ/IM lineage but its expression was virtually mutually exclusive of IgH rearrangement. Low-level cCD79a expression alone should therefore not be interpreted as evidence of B lineage affiliation in immature leukemias. γδ/IM lineage T-ALLs potentially include two distinct categories: predominantly IgH+, cCD79a+, CD127- cases which retain γδ and B lymphoid potential and IgH−, cCD79a−, CD127+ cases with restricted T lineage potential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
LeBien TW . Fates of human B-cell precursors. Blood 2000; 96: 9–23.
Benlagha K, Guglielmi P, Cooper MD, Lassoued K . Modifications of Igalpha and Igbeta expression as a function of B lineage differentiation. J Biol Chem 1999; 274: 19389–19396.
Dworzak MN, Fritsch G, Froschl G, Printz D, Gadner H . Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny. Blood 1998; 92: 3203–3209.
Buccheri V, Mihaljevic B, Matutes E, Dyer MJ, Mason DY, Catovsky D . mb-1: a new marker for B-lineage lymphoblastic leukemia. Blood 1993; 82: 853–857.
Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 1995; 86: 1453–1459.
Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783–1786.
Hashimoto M, Yamashita Y, Mori N . Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma/leukaemias. J Pathol 2002; 197: 341–347.
Finolezzi E, Corral L, Martelli MP, De Propris MS, Falini B, Cimino G . Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3− acute lymphoblastic leukemia. Haematologica 2002; 87: ELT41.
Pilozzi E, Pulford K, Jones M, Muller-Hermelink HK, Falini B, Ralfkiaer E et al. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. J Pathol 1998; 186: 140–143.
Lai R, Juco J, Lee SF, Nahirniak S, Etches WS . Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias. Am J Clin Pathol 2000; 113: 823–830.
Davi F, Faili A, Gritti C, Blanc C, Laurent C, Sutton L et al. Early onset of immunoglobulin heavy chain gene rearrangements in normal human bone marrow CD34+ cells. Blood 1997; 90: 4014–4021.
Bertrand III FE, Billips LG, Burrows PD, Gartland GL, Kubagawa H, Schroeder Jr HW . Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow. Blood 1997; 90: 736–744.
Lassoued K, Nunez CA, Billips L, Kubagawa H, Monteiro RC, LeBlen TW et al. Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell 1993; 73: 73–86.
Fry TJ, Mackall CL . Interleukin-7: from bench to clinic. Blood 2002; 99: 3892–3904.
Reynaud D, Lefort N, Manie E, Coulombel L, Levy Y . In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells. Blood 2003; 101: 4313–4321.
Born W, White J, Kappler J, Marrack P . Rearrangement of IgH genes in normal thymocyte development. J Immunol 1988; 140: 3228–3232.
Szczepanski T, Pongers-Willemse MJ, Langerak AW, Harts WA, Wijkhuijs AJ, van Wering ER et al. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood 1999; 93: 4079–4085.
Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 2003; 101: 2693–2703.
Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, Charrin C et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood 2003; 102: 1000–1006.
Asnafi V, Beldjord K, Libura M, Villarese P, Millien C, Ballerini P et al. Age-related phenotypic and oncogenic differences in T-acute lymphoblastic leukemias may reflect thymic atrophy. Blood 2004, March 30 [E-pub ahead of print].
Zupo S, Isnardi L, Megna M, Massara R, Malavasi F, Dono M et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 1996; 88: 1365–1374.
Brumpt C, Delabesse E, Beldjord K, Davi F, Cayuela JM, Millien C et al. The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype. Blood 2000; 96: 2254–2261.
van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257–2317.
Haks MC, Oosterwegel MA, Blom B, Spits HM, Kruisbeek AM . Cell-fate decisions in early T cell development: regulation by cytokine receptors and the pre-TCR. Semin Immunol 1999; 11: 23–37.
Puel A, Ziegler SF, Buckley RH, Leonard WJ . Defective IL7R expression in T(−)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20: 394–397.
Prieyl JA, LeBien TW . Interleukin 7 independent development of human B cells. Proc Natl Acad Sci USA 1996; 93: 10348–10353.
Author information
Authors and Affiliations
Corresponding author
Additional information
Financial support: This work was supported by the fondation contre la leucémie de la Fondation de France, l'Association de la Recherche sur le Cancer (ARC), the League Contre le Cancer, the Direction de Recherche Clinique de l'Assistance Publique-Hôpitaux de Paris (PHRC 97-106) and the Biomed-2 BMH4-CT98-3936 concerted action.
Rights and permissions
About this article
Cite this article
Asnafi, V., Beldjord, K., Garand, R. et al. IgH DJ rearrangements within T-ALL correlate with cCD79a expression, an immature/TCRγδ phenotype and absence of IL7Rα/CD127 expression. Leukemia 18, 1997–2001 (2004). https://doi.org/10.1038/sj.leu.2403531
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403531